Mohan Sumit, Campenot Eric, Chiles Mariana C, Santoriello Dominick, Bland Eric, Crew R John, Rosenstiel Paul, Dube Geoffrey, Batal Ibrahim, Radhakrishnan Jai, Sandoval P Rodrigo, Guarrera James, Stokes M Barry, D'Agati Vivette, Cohen David J, Ratner Lloyd E, Markowitz Glen
Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons New York, New York;
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York; and.
J Am Soc Nephrol. 2017 Oct;28(10):3109-3117. doi: 10.1681/ASN.2016121330. Epub 2017 Jul 6.
Biopsy findings at the time of procurement of deceased donor kidneys remain the most common reason cited for kidney discard. To determine the value of renal allograft histology in predicting outcomes, we evaluated the significance of histologic findings, read by experienced renal pathologists, in 975 postreperfusion biopsy specimens collected from 2005 to 2009 after living donor (=427) or deceased donor (=548) renal transplant. We evaluated specimens for the degree of glomerulosclerosis, interstitial fibrosis and tubular atrophy, and vascular disease; specimens with a score of 0 or 1 (scale, 0-3) for each parameter were considered optimal. Overall, 66.3% of living donor kidneys and 50.7% of deceased donor kidneys received an optimal histology score (<0.001). Irrespective of donor status, suboptimal kidneys came from older donors with a higher incidence of diabetes mellitus, hypertension, and obesity and a higher mean kidney donor risk index (all <0.001). Death-censored outcomes after transplant differed significantly between optimal and suboptimal kidneys only in the deceased donor transplants (=0.02). Regardless of histologic classification, outcomes with deceased donor kidneys were inferior to outcomes with living donor kidneys. However, 73.2% of deceased donor kidneys with suboptimal histology remained functional at 5 years. Our findings suggest that histologic findings on postreperfusion biopsy associate with outcomes after deceased donor but not living donor renal transplants, thus donor death and organ preservation-related factors may be of greater prognostic importance. Discarding donated kidneys on the basis of histologic factors may be inappropriate and merits further study.
在获取已故供体肾脏时的活检结果仍是肾脏被丢弃的最常见原因。为了确定肾移植组织学在预测预后方面的价值,我们评估了由经验丰富的肾脏病理学家解读的组织学结果在975份再灌注后活检标本中的意义,这些标本于2005年至2009年收集自活体供体(n = 427)或已故供体(n = 548)肾移植后。我们评估了标本的肾小球硬化、间质纤维化和肾小管萎缩程度以及血管病变情况;每个参数评分为0或1(评分范围0 - 3)的标本被认为是最佳的。总体而言,66.3%的活体供体肾脏和50.7%的已故供体肾脏获得了最佳组织学评分(P < 0.001)。无论供体状态如何,次优肾脏来自年龄较大的供体,这些供体患糖尿病、高血压和肥胖症的发生率较高,且肾脏供体风险指数平均值较高(均P < 0.001)。移植后的死亡校正结局在最佳和次优肾脏之间仅在已故供体移植中存在显著差异(P = 0.02)。无论组织学分类如何,已故供体肾脏的结局均不如活体供体肾脏。然而,73.2%组织学次优的已故供体肾脏在5年后仍保持功能。我们的研究结果表明,再灌注后活检的组织学结果与已故供体肾移植后的结局相关,但与活体供体肾移植无关,因此供体死亡和器官保存相关因素可能具有更大的预后重要性。基于组织学因素丢弃捐赠肾脏可能不合适,值得进一步研究。